teriflunomide   Click here for help

GtoPdb Ligand ID: 6844

Synonyms: A77 1726 | Aubagio® | flucyamide | HMR-1726
Approved drug PDB Ligand Immunopharmacology Ligand
teriflunomide is an approved drug (FDA (2012), EMA (2013))
Compound class: Synthetic organic
Comment: Teriflunomide inhibits dihydroorotate dehydrogenase (DHODH). It is the active metabolite of leflunomide.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 73.12
Molecular weight 270.06
XLogP 2.46
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#CC(=C(O)C)C(=O)Nc1ccc(cc1)C(F)(F)F
Isomeric SMILES N#C/C(=C(/O)\C)/C(=O)Nc1ccc(cc1)C(F)(F)F
InChI InChI=1S/C12H9F3N2O2/c1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/h2-5,18H,1H3,(H,17,19)/b10-7-
InChI Key UTNUDOFZCWSZMS-YFHOEESVSA-N
No information available.
Summary of Clinical Use Click here for help
Used to reduce flare-ups in patients with relapsing multiple sclerosis (MS).
Mechanism Of Action and Pharmacodynamic Effects Click here for help
This is the active metabolite of leflunomide. Teriflunomide is an immunomodulatory agent that acts by inhibiting pyrimidine synthesis. A reduction in pyrimidine levels has antiproliferative and anti-inflammatory effects on T cells.
External links Click here for help